Cargando…

The expression of syndecan-1 in psoriatic epidermis

Psoriasis is a chronic inflammatory skin disease characterized by exaggerated keratinocyte proliferation. Current opinion indicates that psoriasis is driven by T cell-mediated immune responses targeting keratinocytes. However, psoriasis cannot be explained solely on the basis of T-cell activation, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomas, Davor, Vučić, Majda, Šitum, Mirna, Krušlin, Božo
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490730/
https://www.ncbi.nlm.nih.gov/pubmed/18386024
http://dx.doi.org/10.1007/s00403-008-0848-z
_version_ 1782158144299859968
author Tomas, Davor
Vučić, Majda
Šitum, Mirna
Krušlin, Božo
author_facet Tomas, Davor
Vučić, Majda
Šitum, Mirna
Krušlin, Božo
author_sort Tomas, Davor
collection PubMed
description Psoriasis is a chronic inflammatory skin disease characterized by exaggerated keratinocyte proliferation. Current opinion indicates that psoriasis is driven by T cell-mediated immune responses targeting keratinocytes. However, psoriasis cannot be explained solely on the basis of T-cell activation, and it is likely that an intrinsic alteration in epidermal keratinocytes plays a very important role in disease expression. Syndecans comprise a major family of cell surface heparan sulfate proteoglycans. Several studies indicate their role in adhesion, cell-extracellular matrix interactions, migration, keratinocyte proliferation and differentiation, inflammation, and wound healing. To determine the expression of syndecan-1 in psoriasis, skin samples from 29 patients with fully developed psoriasis and skin samples from 14 healthy volunteer persons with no personal or family history of psoriasis were immunohistochemically examined using monoclonal antibody against syndecan-1. The expression of syndecan-1 was analyzed in whole mount section of psoriatic and non-psoriatic skin biopsies under high magnification (400×). In addition, the intensity and topography of reaction in the cell, as well as localization of positive cells in the epidermis were evaluated. Strong syndecan-1 reactivity in epidermal cells in all non-psoriatic and psoriatic samples was observed. Statistical analysis showed no significant differences between two analyzed groups (P > 0.05). In normal skin syndecan-1 was expressed in full thickness of the epidermis. The strongest reaction was observed in membranes and intercellular junctions of spinous and granular layer while basal cells showed weaker expression that was confined to cytoplasm. In psoriatic skin syndecan-1 was expressed in the membrane and intercellular junction of cells located in thickened and elongated rete ridges of the epidermis. The strongest reaction was in basal and suprabasal layers and expression diminished through spinous layer. Cells in spinous layer lose syndecan-1 expression, which is opposite pattern to normal skin. Our results suggest that aberrant skin expression of syndecan-1 may be involved in the development of psoriasis.
format Text
id pubmed-2490730
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-24907302008-07-30 The expression of syndecan-1 in psoriatic epidermis Tomas, Davor Vučić, Majda Šitum, Mirna Krušlin, Božo Arch Dermatol Res Short Communication Psoriasis is a chronic inflammatory skin disease characterized by exaggerated keratinocyte proliferation. Current opinion indicates that psoriasis is driven by T cell-mediated immune responses targeting keratinocytes. However, psoriasis cannot be explained solely on the basis of T-cell activation, and it is likely that an intrinsic alteration in epidermal keratinocytes plays a very important role in disease expression. Syndecans comprise a major family of cell surface heparan sulfate proteoglycans. Several studies indicate their role in adhesion, cell-extracellular matrix interactions, migration, keratinocyte proliferation and differentiation, inflammation, and wound healing. To determine the expression of syndecan-1 in psoriasis, skin samples from 29 patients with fully developed psoriasis and skin samples from 14 healthy volunteer persons with no personal or family history of psoriasis were immunohistochemically examined using monoclonal antibody against syndecan-1. The expression of syndecan-1 was analyzed in whole mount section of psoriatic and non-psoriatic skin biopsies under high magnification (400×). In addition, the intensity and topography of reaction in the cell, as well as localization of positive cells in the epidermis were evaluated. Strong syndecan-1 reactivity in epidermal cells in all non-psoriatic and psoriatic samples was observed. Statistical analysis showed no significant differences between two analyzed groups (P > 0.05). In normal skin syndecan-1 was expressed in full thickness of the epidermis. The strongest reaction was observed in membranes and intercellular junctions of spinous and granular layer while basal cells showed weaker expression that was confined to cytoplasm. In psoriatic skin syndecan-1 was expressed in the membrane and intercellular junction of cells located in thickened and elongated rete ridges of the epidermis. The strongest reaction was in basal and suprabasal layers and expression diminished through spinous layer. Cells in spinous layer lose syndecan-1 expression, which is opposite pattern to normal skin. Our results suggest that aberrant skin expression of syndecan-1 may be involved in the development of psoriasis. Springer-Verlag 2008-04-02 2008 /pmc/articles/PMC2490730/ /pubmed/18386024 http://dx.doi.org/10.1007/s00403-008-0848-z Text en © The Author(s) 2008 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Short Communication
Tomas, Davor
Vučić, Majda
Šitum, Mirna
Krušlin, Božo
The expression of syndecan-1 in psoriatic epidermis
title The expression of syndecan-1 in psoriatic epidermis
title_full The expression of syndecan-1 in psoriatic epidermis
title_fullStr The expression of syndecan-1 in psoriatic epidermis
title_full_unstemmed The expression of syndecan-1 in psoriatic epidermis
title_short The expression of syndecan-1 in psoriatic epidermis
title_sort expression of syndecan-1 in psoriatic epidermis
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490730/
https://www.ncbi.nlm.nih.gov/pubmed/18386024
http://dx.doi.org/10.1007/s00403-008-0848-z
work_keys_str_mv AT tomasdavor theexpressionofsyndecan1inpsoriaticepidermis
AT vucicmajda theexpressionofsyndecan1inpsoriaticepidermis
AT sitummirna theexpressionofsyndecan1inpsoriaticepidermis
AT kruslinbozo theexpressionofsyndecan1inpsoriaticepidermis
AT tomasdavor expressionofsyndecan1inpsoriaticepidermis
AT vucicmajda expressionofsyndecan1inpsoriaticepidermis
AT sitummirna expressionofsyndecan1inpsoriaticepidermis
AT kruslinbozo expressionofsyndecan1inpsoriaticepidermis